44
Views
31
CrossRef citations to date
0
Altmetric
Biomarkers of Susceptibility

Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones

, , , , , , , , & show all
Pages 85-92 | Received 11 Jun 2003, Accepted 26 Jan 2004, Published online: 22 Jan 2010
 

Abstract

Recent studies have shown that C-reactive proteins have a pathogenetic role in atherothrombosis and concentrations of these substances could be used as a marker for future vascular events. The objective of this study was to determine gender differences in highly sensitive C-reactive protein (hs-CRP) in individuals with atherothrombotic risk factors and apparently healthy ones. We have presently matched 469 females and 469 males having the same age and body mass index (BMI). Of these, 210 men and 210 women had no atherothrombotic risk factors. In this group the hs-CRP concentrations were 1.6±3.4 mg l−1 in women and 1.0±2.7 mg l−1 in men (p<0.0005). These values were 2.1±3.4 mg l−1 and 1.5±2.8 mg l−1, respectively, in the entire cohort (p<0.0005), which included also individuals with atherothrombotic risk factors. We conclude that significant gender differences exist in hs-CRP concentrations despite perfect matching for age and BMI. These differences should be reflected in guidelines that suggest hs-CRP cut-off points for the stratification of vascular risk.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.